Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Understanding the pros of zero based budgeting can empower you to take control of your finances. Learn how this approach can benefit your budgeting efforts.
15,688 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
World Cup bets on Polymarket surged to $3.3 billion in trading volume, eclipsing the Super Bowl and drawing attention...
MP Materials stands at the crossroads of national strategy and market demand for critical minerals. This guide outlin...
The market is navigating a phase many haven’t seen in a generation. Mega-cap tech dominates, valuations look stretche...
SpaceX's IPO excitement gave way to a pullback, leaving investors wondering about future gains. This guide breaks dow...
Memory names slide as risk appetite shifts toward cyclicals, but persistent supply constraints and improving contract...
A bigger 2027 COLA might sound like easy money for Social Security beneficiaries. But the real impact goes beyond big...
In 2026, one AI-focused stock has become the darling of bulls and analysts alike. This article dives into the reasons...
A bold AI-based forecast from Meta envisions Bitcoin surging toward multi-year highs by year-end 2026, anchored by re...
Bitcoin now requires far larger inflows to ignite a bull run, a shift CryptoQuant CEO Ki Young Ju attributes to marke...
A senior insider at Septerna sold nearly 12,000 shares in a single move, raising questions for investors. This articl...
A bold forecast meets practical analysis. Explore why prediction: intuitive surgical will may become a reality by 203...